| (Values in U.S. Thousands) | Apr, 2022 | Jan, 2022 | Oct, 2021 | Jul, 2021 | Apr, 2021 |
| Sales | 0 | 0 | 0 | 0 | 20 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | 0 | 0 | 0 | 0 | 9,220 |
| Net Income Growth | unch | unch | unch | unch | +138.29% |
Generex Biotechnology Corporatio (GNBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Generex Biotechnology Corporation provides research, development, and commercialization of drug delivery systems and technologies. The company's products include Generex Oral-lyn, Glucose RapidSpray, BaBOOM Energy Spray and Crave-NX. It markets its products primarily in Ecuador, Canada, and the United States. Generex Biotechnology Corporation is based in Toronto, Canada.